First MINIject surgery completed in the UK


iStar Medical announced the expansion of its commercial rollout of its MIGS implant MINIject® to the UK.

First MINIject surgery completed in the UK

iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients today, recently announced it has further expanded its commercial rollout for MINIject® to the UK.

According to a press release, MINIject® is iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) implant, and is currently the only commercially available supraciliary MIGS device. It is designed to enhance natural fluid outflow, reduce intraocular pressure (IOP) and the need for medication, while bio-integrating with surrounding tissue, limiting inflammation, fibrosis and subsequent complications.

This expansion allows patients in the UK living with open angle glaucoma the benefit of the implant, which has demonstrated “meaningful and sustained performance, combined with a favourable safety profile,” the release states.

The first implants with MINIject have been successfully completed at The Colchester Eye Centre of Excellence (US) by Dr Chrys Dimitriou, consultant ophthalmic surgeon in cataract and glaucoma and specialist in MIGS.

Glaucoma, the leading cause of irreversible blindness, affects around 100 million people worldwide and approximately 10 million in Europe alone, according to the release. It goes on to say that “MIGS represents the most promising and fastest-growing glaucoma therapy, due to its enhanced safety profile compared to traditional surgery.”1

1. Market Scope, “2021 Glaucoma Surgical Device Market Report”, July 2021.
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.